Projects per year
Fingerprint Dive into the research topics where Tyler J Curiel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 9 Similar Profiles
Neoplasms
Medicine & Life Sciences
Immunotherapy
Medicine & Life Sciences
Regulatory T-Lymphocytes
Medicine & Life Sciences
Toxoplasma
Medicine & Life Sciences
T-Lymphocytes
Medicine & Life Sciences
Ovarian Neoplasms
Medicine & Life Sciences
Dendritic Cells
Medicine & Life Sciences
T-cells
Chemical Compounds
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1978 2020
San Antonio Claude D. Pepper Older Americans Independence Center
Curiel, T. J., Tardif, S. D., Musi, N., Gelfond, J. A. L., Gelfond, J. A. & Strong, J. R.
6/15/15 → 4/30/20
Project: Research project
Callithrix
Research
Research Personnel
Pharmacology
Health
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
Project: Research project
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
Project: Research project
Research Output 1982 2019
Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial
Ji, N., Mukherjee, N., Morales, E. E., Tomasini, M. E., Hurez, V., Curiel, T. J., Abate, G., Hoft, D. F., Zhao, X. R., Gelfond, J. A., Maiti, S., Cooper, L. J. N. & Svatek, R., Jan 1 2019, In : OncoImmunology.Research output: Contribution to journal › Article
Urinary Bladder Neoplasms
Bacillus
Clinical Trials
Natural Killer T-Cells
Therapeutics
2
Citations
(Scopus)
Rapamycin prevents surgery-induced immune dysfunction in patients with bladder cancer
Svatek, R., Ji, N., De Leon, E., Mukherjee, N. Z., Kabra, A., Hurez, V., Nicolas, M., Michalek, J. E., Javors, M. A., Wheeler, K., Dave Sharp, Z., Livi, C. B., Shu, Z. J., Henkes, D. & Curiel, T. J., Mar 1 2019, In : Cancer Immunology Research. 7, 3, p. 466-475 10 p.Research output: Contribution to journal › Article
Sirolimus
Urinary Bladder Neoplasms
T-Lymphocytes
Neoplasms
Neoplasm Metastasis
4
Citations
(Scopus)
Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
Wu, B., Sun, X., Gupta, H. B., Yuan, B., Li, J., Ge, F., Chiang, H. C., Zhang, X., Zhang, C., Zhang, D., Yang, J., Hu, Y., Curiel, T. J. & Li, R., Jan 1 2018, (Accepted/In press) In : OncoImmunology.Research output: Contribution to journal › Article
Immunotherapy
Breast Neoplasms
Ligands
Adipocytes
Adipose Tissue
6
Citations
(Scopus)
Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model
Padrón, Á., Hurez, V., Gupta, H. B., Clark, C. A., Pandeswara, S. L., Yuan, B., Svatek, R., Turk, M. J., Drerup, J. M., Li, R. & Curiel, T. J., Jan 1 2018, (Accepted/In press) In : Experimental Gerontology.Research output: Contribution to journal › Article
Melanoma
T-cells
Neoplasms
Blocking Antibodies
Regulatory T-Lymphocytes
19
Citations
(Scopus)
A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects
Kraig, E. B., Linehan, L. A., Liang, H., Romo, T. Q., Liu, Q., Wu, Y., Benavides, A. D., Curiel, T. J., Javors, M. A., Musi, N., Chiodo, L., Koek, W., Gelfond, J. A. & Kellogg Jr, D. L., Jan 1 2018, (Accepted/In press) In : Experimental Gerontology.Research output: Contribution to journal › Article
Sirolimus
Safety
Therapeutics
Erythrocyte Indices
Clinical laboratories
Press/Media
A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer; ONTAK
10/2/18
1 item of Media coverage
Press/Media: Press / Media
A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer
10/2/18
1 item of Media coverage
Press/Media: Press / Media
Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
10/2/18
1 item of Media coverage
Press/Media: Press / Media
Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors
10/2/18
1 item of Media coverage
Press/Media: Press / Media
Agenus Announces Key Leadership to Advance Combination Trials For Planned BLA Filings; -- Hagop Youssoufian, MD, named Senior Clinical Strategist
1/3/18 → 1/5/18
19 items of Media coverage
Press/Media: Press / Media